SEBI Cracks Down on Seven Entities for Social Media Stock Manipulation Freezes 20 Crore Gains Telecom CEO Warns Europe Faces Vulnerability to US Dominance in Satellites and AI SP 500 Edges Higher as Healthcare and Technology Lead BroadBased Gains Vertiv Launches New Standby Power Series for North American Data Centers National Football League Calls for Ban on Certain Prediction Market Contracts Citing Integrity Concerns Natural Gas Futures Dip as Weather Forecasts Moderate KLAR Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher BNS Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operating Performance LASR Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Amid Strategic Shifts NEON Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap IRS Q1 2026 Earnings Significant Loss Reported Amidst Argentine Economic Challenges AVIR Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Galapagos NV GLPG Holds Steady Near Resistance Consolidation or Catalyst Ahead First Guaranty Bancshares Surges 7 Testing Key Resistance at 994 Intergroup Corporation INTG Edges Lower as Price Tests Key Support Near 40 Cushman Wakefield CWK Edges Higher Amid Mixed Market Sentiment NextCure NXTC Plunges Over 22 as Selling Pressure Intensifies Micron Technology Shares Eye Best Monthly Performance Since 1987 Analysts Flag Value Opportunity 5E Advanced Materials Inc FEAM Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Phase Continues Karman Holdings KRMN Holds Near Support After Modest Decline IDN Q1 2026 Earnings Strong EPS Beat Fuels Optimism Despite Lack of Revenue Detail PNNT Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction QNST Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Mixed Signals DLPN Q1 2026 Earnings WiderthanExpected Loss Pressures Sentiment as Revenue Remains Undisclosed MTX Q1 2026 Earnings EPS Surpasses Estimates by 887 Amid Solid Operational Performance TWOD Q1 2026 Earnings Strong EPS Beat Amid Challenging Mortgage Market AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline